These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32189036)

  • 1. Time- and temperature-dependent postmortem concentration changes of the (synthetic) cannabinoids JWH-210, RCS-4, as well as ∆9-tetrahydrocannabinol following pulmonary administration to pigs.
    Schaefer N; Kröll AK; Körbel C; Laschke MW; Menger MD; Maurer HH; Meyer MR; Schmidt PH
    Arch Toxicol; 2020 May; 94(5):1585-1599. PubMed ID: 32189036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is adipose tissue suitable for detection of (synthetic) cannabinoids? A comparative study analyzing antemortem and postmortem specimens following pulmonary administration of JWH-210, RCS-4, as well as ∆9-tetrahydrocannabinol to pigs.
    Schaefer N; Nordmeier F; Kröll AK; Körbel C; Laschke MW; Menger MD; Maurer HH; Meyer MR; Schmidt PH
    Arch Toxicol; 2020 Oct; 94(10):3421-3431. PubMed ID: 32666126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of the (synthetic) cannabinoids JWH-210, RCS-4, as well as ∆9-tetrahydrocannabinol following pulmonary administration to pigs.
    Schaefer N; Kröll AK; Körbel C; Laschke MW; Menger MD; Maurer HH; Meyer MR; Schmidt PH
    Arch Toxicol; 2019 Aug; 93(8):2211-2218. PubMed ID: 31227841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs.
    Schaefer N; Kettner M; Laschke MW; Schlote J; Ewald AH; Menger MD; Maurer HH; Schmidt PH
    Curr Neuropharmacol; 2017; 15(5):713-723. PubMed ID: 27834143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans?
    Schaefer N; Helfer AG; Kettner M; Laschke MW; Schlote J; Ewald AH; Meyer MR; Menger MD; Maurer HH; Schmidt PH
    Drug Test Anal; 2017 Apr; 9(4):613-625. PubMed ID: 27328899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can toxicokinetics of (synthetic) cannabinoids in pigs after pulmonary administration be upscaled to humans by allometric techniques?
    Schaefer N; Wojtyniak JG; Kroell AK; Koerbel C; Laschke MW; Lehr T; Menger MD; Maurer HH; Meyer MR; Schmidt PH
    Biochem Pharmacol; 2018 Sep; 155():403-418. PubMed ID: 30048626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of (synthetic) cannabinoids in pigs and their relevance for clinical and forensic toxicology.
    Schaefer N; Wojtyniak JG; Kettner M; Schlote J; Laschke MW; Ewald AH; Lehr T; Menger MD; Maurer HH; Schmidt PH
    Toxicol Lett; 2016 Jun; 253():7-16. PubMed ID: 27113702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an In-vitro Drug Delivery Efficiency Test for a Pulmonary Toxicokinetic Pig Study.
    Schaefer N; Kroll AK; Laschke MW; Menger MD; Maurer HH; Meyer MR; Schmidt PH
    Curr Drug Deliv; 2018; 15(8):1167-1171. PubMed ID: 29446742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are the (New) Synthetic Opioids U-47700, Tramadol and Their Main Metabolites Prone to Time-Dependent Postmortem Redistribution?-A Systematic Study Using an In Vivo Pig Model.
    Nordmeier F; Doerr AA; Potente S; Walle N; Laschke MW; Menger MD; Schmidt PH; Meyer MR; Schaefer N
    J Anal Toxicol; 2023 Mar; 47(3):236-244. PubMed ID: 36242582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perimortem Distribution of U-47700, Tramadol and Their Main Metabolites in Pigs Following Intravenous Administration.
    Nordmeier F; Doerr AA; Potente S; Walle N; Laschke MW; Menger MD; Schmidt PH; Meyer MR; Schaefer N
    J Anal Toxicol; 2022 May; 46(5):479-486. PubMed ID: 33950247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous LC-MS/MS determination of JWH-210, RCS-4, ∆(9)-tetrahydrocannabinol, and their main metabolites in pig and human serum, whole blood, and urine for comparing pharmacokinetic data.
    Schaefer N; Kettner M; Laschke MW; Schlote J; Peters B; Bregel D; Menger MD; Maurer HH; Ewald AH; Schmidt PH
    Anal Bioanal Chem; 2015 May; 407(13):3775-86. PubMed ID: 25772567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.
    Carlier J; Scheidweiler KB; Wohlfarth A; Salmeron BD; Baumann MH; Huestis MA
    J Chromatogr A; 2016 Jun; 1451():97-106. PubMed ID: 27208987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic properties of the synthetic cannabinoid JWH-018 in oral fluid after inhalation.
    Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
    Drug Test Anal; 2018 Apr; 10(4):644-650. PubMed ID: 28967189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice.
    Wiley JL; Lefever TW; Marusich JA; Grabenauer M; Moore KN; Huffman JW; Thomas BF
    Neuropharmacology; 2016 Nov; 110(Pt A):143-153. PubMed ID: 27449567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of new classes of recreational drugs in sewage: synthetic cannabinoids and amphetamine-like substances.
    Reid MJ; Derry L; Thomas KV
    Drug Test Anal; 2014; 6(1-2):72-9. PubMed ID: 23460377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male Rats.
    Carlier J; Wohlfarth A; Salmeron BD; Scheidweiler KB; Huestis MA; Baumann MH
    J Pharmacol Exp Ther; 2018 Dec; 367(3):543-550. PubMed ID: 30266766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method for Postmortem Quantification of Δ9-Tetrahydrocannabinol and Metabolites Using LC-MS-MS.
    Al-Asmari AI
    J Anal Toxicol; 2019 Oct; 43(9):703-719. PubMed ID: 31665339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of a selection of synthetic cannabinoids and metabolites in urine by UHPSFC-MS/MS and by UHPLC-MS/MS.
    Berg T; Kaur L; Risnes A; Havig SM; Karinen R
    Drug Test Anal; 2016 Jul; 8(7):708-22. PubMed ID: 26304456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques.
    Hutter M; Broecker S; Kneisel S; Auwärter V
    J Mass Spectrom; 2012 Jan; 47(1):54-65. PubMed ID: 22282090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction.
    Kneisel S; Auwärter V
    J Mass Spectrom; 2012 Jul; 47(7):825-35. PubMed ID: 22791249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.